葛兰素史克预计2026年销售额增速放缓

环球市场播报
Feb 04

  葛兰素史克于周三发布2026年业绩展望,预计销售额增速将放缓。这是新任首席执行官Luke Miels首次公布业绩预期,目前该药企正将重心转向扩充研发管线,以应对旗下畅销艾滋病药物即将到来的专利到期问题。

  按固定汇率计算,葛兰素史克预计2026年营收增幅为3%至5%,而公司2025年营收增幅为7%。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:李肇孚

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10